Advances in HIV therapeutics: news from the 4th International AIDS Society Conference.

B. Boyle,R. Elion,C. Cohen,E. Dejesus,T. Hawkins,G. Moyle
2007-10-01
Abstract:The Fourth International AIDS Society Conference on HIV Pathogenesis, Treatment, and Prevention (4th IAS Conference) was held in Sydney, Australia, from July 22 to 25, 2007. This year provided some significant new insights into HIV therapeutics, especially in reducing the risk of abacavir hypersensitivity reactions, the use of novel agents in treatment-naive patients, and the use of darunavir and etravirine (a new NNRTI) in treatment-experienced patients. [See our September issue for a report from Dr William Valenti, University of Rochester School of Medicine and Dentistry, on the important findings related to the metabolic syndrome presented at the 4th IAS Conference.—Ed]
What problem does this paper attempt to address?